KEATON ORSZT: Open Payments
NPI 1568912202 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$630 in 22 payments from 9 companies in 2025. Trend: 2023 $120 · 2024 $83 · 2025 $630
Food & beverage: $630
| Company | Payments | Amount |
|---|---|---|
| ConvaTec Inc. | 5 | $168 |
| Sumitomo Pharma America, Inc. | 3 | $110 |
| Boston Scientific Corporation | 3 | $109 |
| Antares Pharma, Inc. | 5 | $107 |
| 180 Medical, Inc. | 2 | $49 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| Endo USA, Inc. | 1 | $26 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $17 |
| Telix Pharmaceuticals | 1 | $14 |
Products named: GENTLECATH GLIDE, GEMTESA, XYOSTED, Rezum Generator, GENTLECATH, LYNPARZA, LithoVue, AVEED.
Industry payments across WA — which companies pay providers there.
